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Abstract 23 
 2 
 
Cinnamaldehyde (CNMA), an organic compound that gives cinnamon its flavor and 24 
odor, was investigated for its virucidal activity on norovirus surrogates, murine 25 
norovirus (MNV) and feline calicivirus (FCV), and hepatitis A virus (HAV). Initially, 26 
different concentrations of CNMA (0.1, 0.5 and 1%) were individually mixed with each 27 
virus at titers of ca. 6-7 log10 TCID50/ml and incubated 2 h at 4 and 37 °C. CNMA was 28 
effective in reducing the titers of norovirus surrogates in a dose-dependent manner after 29 
2 h at 37 °C, while HAV titers were reduced by 1 log10 after treatment with 1% of 30 
CNMA. When incubation time was extended, HAV titers were reduced by 3.4 and 2.7 31 
log10 after overnight incubation at 37 °C with 1 and 0.5 % of CNMA, respectively. 32 
Moreover, this paper analyzed, for the first time, the antiviral activity of adding an 33 
active electrospun interlayer based on zein and CNMA to a polyhydroxybutyrate 34 
packaging material (PHB) in a multilayer form. Biodegradable multilayer systems 35 
prepared with 2.60 mg/cm2 ( 9.7%) of CNMA completely inactivated FCV according 36 
to ISO 22196:2011, while MNV titers were reduced by 2.75 log10. When the developed 37 
multilayer films were evaluated after one month of preparation or at 25 °C, the antiviral 38 
activity was reduced as compared to freshly prepared multilayer films evaluated at 37 39 
°C.  40 
The results show the excellent potential of this system for food contact applications as 41 
well as for active packaging technologies in order to maintain or extend food quality 42 
and safety. 43 
 44 
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1. Introduction 48 
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Enteric viruses are viruses that are primarily transmitted by the fecal-oral route, either 49 
by person-to-person contact or by ingestion of contaminated food or water. For most 50 
food products, handling is often the source of contamination, while shellfish is most 51 
commonly contaminated by fecally polluted water in the harvesting area.  52 
Moreover, enteric viruses, in particular human norovirus (NoV), are the leading causes 53 
of foodborne illnesses in industrialized countries (Anonymous, 2013; EFSA, 2015), 54 
while hepatitis A virus (HAV) has recently been considered as a re-emerging foodborne 55 
public health threat in Europe due to the number of foodborne outbreaks associated to 56 
imported foods (Sprenger, 2014).   57 
Cinnamaldehyde (CNMA) is the major component in cassia and cinnamon bark oils. 58 
CNMA is Generally Recognized As Safe (GRAS) by the Flavoring Extract 59 
Manufacturers' Association and is approved for food use (21 CFR 182.60) by the Food 60 
and Drug Administration (FDA) to impart a cinnamon flavour in numerous foods.  61 
Furthermore, CNMA is known to have anti-inflammatory (Youn et al. 2008), 62 
antioxidant and antimicrobial properties (reviewed by Patel, 2015). Although 63 
bactericidal efficacy of CNMA is well established, current knowledge of the antiviral 64 
efficacy is limited and requires investigation (Liu et al. 2009).  65 
Due to the beneficial properties of CNMA, its use for food applications is a growing 66 
field of interest, either in washing solutions or incorporated into packaging materials 67 
(Burt, 2004). In this sense, the antimicrobial activity of CNMA incorporated into 68 
alginate (Raybaudi-Massilia et al. 2008), polycaprolactone (Martínez-Abad et al. 69 
2013b), polypropylene (Gutiérrez et al. 2009), polyethylene-co-vinylacetate (Nostro et 70 
al. 2012), polylactic acid (Qin et al. 2015), chitosan (Peng & Li, 2014), starch (De 71 
Souza et al. 2014) and apple-based edible films (Ravishankar et al. 2009) has 72 
extensively been evaluated as an alternative to the modified atmosphere packaging and 73 
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addition of preservatives. However, the addition of essential oils or its active 74 
biomolecules to food or packaging materials at concentrations that resist the 75 
conventional thermal treatments may also affect the organoleptic properties of the food 76 
product (Vergis et al. 2015).  77 
Because none of the currently available pure biodegradable polymer material exhibits 78 
all the desired mechanical and barrier properties required for every conceivable food 79 
packaging application, complex multilayer films are suggested as suitable systems to 80 
tune the performance of biopolymers. In this sense, Fabra et al. (2013) successfully 81 
developed an innovative route based on the electrospinning processing to produce 82 
biodegradable multilayer food packaging structures based on polyhydroxybutyrate 83 
(PHB) outer layers with an electrospun zein interlayer which showed enhanced barrier 84 
and mechanical properties. Electrospinning is a simple, versatile and efficient method to 85 
produce high-performance polymeric fibres with diameters ranging from the micro to 86 
the nanoscale. This technique relies on the application of electrostatic forces to draw 87 
polymer solutions or melts into ultrathin fibers, which can be deposited as fibrous mats 88 
for many potential applications (Huang, Zhang, Kotaki, & Ramakrishna, 2003). Taking 89 
into account that many active agents are thermally sensitive and, thus, cannot be directly 90 
incorporated during typical processing methods used for biopolymeric materials, the 91 
electrospinning process already described could be of interest to develop new active 92 
packaging systems with the additional advantage of simultaneously producing 93 
interlayers with encapsulation performance.  94 
Pioneering studies demonstrated the potential of natural compounds (e.g. grape seed 95 
extract (GSE) and carvacrol) to control enteric viruses in food applications (Sánchez et 96 
al. 2015; Su & Souza, 2013) and the potential of antimicrobial packaging for virus 97 
inactivation (Bright et al. 2009; Martínez-Abad et al. 2013a). Therefore, to expand the 98 
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scope of active packaging and antimicrobial surfaces, the effect of CNMA on the 99 
infectivity of HAV and two norovirus surrogates, murine norovirus (MNV) and feline 100 
calicivirus (FCV) was evaluated. Furthermore, CNMA was encapsulated within the 101 
electrospun zein interlayer conferring the active character to the multilayer packaging 102 
structures. It is presumed that the virucidal activity of this compound (which was 103 
applied within the multilayers) could be preserved by the encapsulation process induced 104 
by the electrospinning technique here applied to produce the electrospun interlayer. 105 
Thus, the efficacy of these multilayer structures containing CNMA in reducing viral 106 
loads was also analysed.  107 
 108 
2. Material and methods 109 
2.1. Virus cultivation and infectivity 110 
Feline calicivirus (F9 strain, ATCC VR-782) was cultured in CRFK (ATCC CCL-94) 111 
cells. Murine norovirus (MNV-1 strain; kindly provided by Prof. H. W. Virgin, 112 
Washington University School of Medicine, USA) was propagated and assayed in 113 
RAW 264.7 (kindly provided by Prof. H. W. Virgin). The HM-175/18f strain of HAV 114 
(ATCC VR-1402) was propagated and assayed in FRhK-4 cells (kindly provided by 115 
Prof. Albert Bosch, University of Barcelona). Semi-purified viruses were obtained 116 
following three cycles of freeze-thawing infected cells and centrifugation at 660×g for 117 
30 min. The supernatant was stored at -80°C until use. Infectious viruses were 118 
enumerated by determining the 50% tissue culture infectious dose (TCID50) with eight 119 
wells per dilution and 20 μl of inoculum per well using the Spearman-Karber method 120 
(Pintó et al. 1994). 121 
 122 
2.2. CNMA cytotoxicity on cell monolayers 123 
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Different concentrations of CNMA (3-Phenylprop-2-enal; ≥95% purity; Sigma Aldrich) 124 
were added to 96-well cell-culture plates containing a monolayer of RAW 264.7, CRFK 125 
and FRhK-4 cells and incubated 2 h at 37 °C under 5% CO2. Thereafter, cells were 126 
added with 150 µl of DMEM supplemented with 2% of fecal calf serum (FCS) and 127 
incubated further for 2 to 10 days. Cytotoxicity effects were determined by both visual 128 
inspection under the optical microscope and Vybrant® MTT Cell Proliferation Assay 129 
Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. 130 
 131 
2.3. Antiviral activity of CNMA on virus suspensions 132 
Each CNMA solution diluted in 50% ethanol was mixed with an equal volume of each 133 
virus suspension (6-7 log10 TCID50/ml) and further incubated at 4 or 37 °C in a water-134 
bath shaker at 150 rpm for 2 or 16 h (ON). Then, infectious viruses were enumerated by 135 
cell culture assays as described above. Positive controls were virus suspensions added 136 
with ethanol in amounts corresponding to the highest quantity present. Each treatment 137 
was done in triplicate. Antiviral activity of CNMA was estimated by comparing the 138 
number of infectious viruses on suspensions without CNMA and on the CNMA-treated 139 
virus suspensions. 140 
2.4. Preparation of multilayer PHB based films 141 
2.4.1. Preparation of PHB films 142 
PHB films were prepared by compression-molding. To this end, 3 g of PHB pellets 143 
(Biomerc ® 226, Germany) were compression-molded into films using a hot plate 144 
hydraulic press (Carver 4122, USA) at 175 ºC and 2 MPa for 3 min.   145 
 146 
2.4.2. Preparation of electrospun zein and zein/CNMA interlayers by electrospinning 147 
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Zein ultrathin nanostructured interlayers were obtained as described by Fabra et al. 148 
(2013). Briefly, zein fibers were obtained from the electrospinning of 33 wt.-% of zein 149 
in an 80% v/v ethanol/water solution prepared under magnetic stirring at 25 ºC, using a 150 
voltage of 14 kV and a flow rate of 0.75 mL h-1. The electrospinning apparatus was a 151 
Fluidnatek LE10 basic equipment by Bioinicia S.L., Paterna (Spain), that makes use of 152 
a single needle to electrospun the polymeric solution. The zein/CNMA interlayers were 153 
identically prepared but, in this case, CNMA (75 wt.-% respect to the protein weight) 154 
was previously incorporated and stirred for 30 min.  155 
The zein and zein/CNMA ultrathin fibers were directly collected onto one side of the 156 
PHB films for 6 hours to have 1.07 ± 0.08 g of the nanostructured layer. The amount of 157 
electrospun zein or zein/CNMA interlayer was calculated by weighing the PHB film 158 
before and after the collection of fibers. The mass fraction of the CNMA in the resulting 159 
multilayer system (Area = 176.72 cm2) was very low (xCNMA = 0.097) which means that 160 
2.60 mg/cm2 of CNMA (or  9.7 %) were deposited. 161 
 162 
2.4.3. Multilayer assembly 163 
Once the electrospun zein and zein/CNMA mats were collected onto the inner side of 164 
the PHB films, they were covered with another similarly prepared PHB film. The 165 
multilayer structures were then heated in a hot press (Carver 4122) at 160 ºC during 2 166 
min (without pressing) to promote fiber coalescence, hence becoming a very thin layer 167 
with controlled morphology, and also interlayer adhesion. Multilayer structures 168 
prepared with nanostructured zein interlayer will be named as control and those 169 
containing zein/CNMA interlayers will be called active multilayer films or CNMA 170 
multilayer films throughout the manuscript. Films were stored in 100% relative 171 
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humidity desiccators at 24 ± 2 ºC protected from light with aluminum wrapping before 172 
undergoing testing. 173 
 174 
2.5. Determination of virucidal activity 175 
To test the virucidal activity of active CNMA multilayer systems, a modification of the 176 
ISO 22196:2011 (Measurement of antibacterial activity on plastics and other non-177 
porous surfaces) was used. Briefly, a suspension of viruses diluted in PBS buffer (4-6 178 
log10 TCID50/ml) was placed onto the test films of 3×3 cm and covered by an inert piece 179 
of Low-Density Polyethylene (LDPE) of 2.5×2.5 cm and 10 μm thickness. Samples 180 
were incubated at 37 or 25 °C overnight (ON) at 100% relative humidity. Thereafter, 181 
the top film was lifted, and the virus droplet-exposed sides were recovered and 10-fold 182 
diluted with PBS. Lastly, the corresponding cell culture assays were performed to 183 
determine whether the multilayer films were effective in inactivating the viruses. A 184 
control film (without CNMA) was used as the negative control material. 185 
Virucidal activity was calculated by comparing the number of infectious viruses on 186 
multilayer control films (without CNMA) and on the CNMA multilayer films. Each 187 
experimental condition was analyzed in triplicate. 188 
 189 
2.6. Scanning Electron Microscopy (SEM). 190 
SEM was conducted on a Hitachi microscope (Hitachi S-4800) at an accelerating 191 
voltage of 10 kV and a working distance of 8-10 mm. After immersion in liquid 192 
nitrogen, cryo-fractured multilayer systems were sputtered with a gold-palladium 193 
mixture under vacuum and their morphology was subsequently examined using SEM. 194 
 195 
 196 
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2.7. Statistical analysis 197 
The significance of differences among the mean numbers of viruses determined after the 198 
various treatments was determined by Student's t test with a significance level of P < 199 
0.05 (Microsoft Office Excel; Microsoft, Redmond, WA, USA). 200 
 201 
3. Results 202 
3.1. Determination of CNMA toxicity 203 
CNMA was found to be cytotoxic for the three cell lines at concentrations that exceeded 204 
1%. Therefore this value was the maximum concentration of CNMA tested to evaluate 205 
its effect on MNV, FCV and HAV. 206 
3.2. Effect of CNMA on norovirus surrogates and HAV 207 
CNMA was found to be effective in reducing viral titers of norovirus surrogates and 208 
HAV depending on contact time and temperature. While incubation of CNMA at 4 °C 209 
for 2 hours had not effect on the three viruses (Table 1), overnight incubation with 210 
CNMA at 0.5 and 1% at 4 °C statistically decreased the titers of FCV (p < 0.05) (Table 211 
2). Incubation of MNV and FCV with CNMA at concentrations of 0.5 and 1% for 2 h at 212 
37 °C significantly decreased (p < 0.05) the titers of the two norovirus surrogates while 213 
CNMA at 1% decreased HAV titers by 1 log10  (Table 1). 214 
When overnight incubations were performed at 37 °C, CNMA was found to be more 215 
effective on MNV and HAV. CNMA at 0.5 and 1% reduced MNV titers to undetectable 216 
levels, while CNMA at 0.1% reduced MNV titers by 1.7 log10. Furthermore, CNMA 217 
was effective in reducing the titers of HAV in a dose-dependent manner, where 218 
increasing concentrations of CNMA resulted in increased reduction in viral titers (Table 219 
2). Efficacy on FCV was not established since the virus control was not surviving the 220 
experimental conditions (i.e. ON incubation at 37 °C). 221 
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3.3. Morphology of multilayer structures based on PHB and electrospun zein/CNMA 222 
interlayers 223 
The cross-section of the multilayer systems was analyzed by SEM and representative 224 
micrographs of each sample are displayed in Figure 1. From these images, the 225 
interphase between the PHB outer layers and the interlayer was clearly observed in both 226 
control and active multilayer structures. As reported in previous works (Fabra et al. 227 
2013; Fabra et al. 2014), the developed multilayer systems showed laminar like 228 
structures in which the zein and zein/CNMA interlayers (ca. 32 µm) were thinner than 229 
the outer layers (ca. 78 µm) and presented a strong adhesion to the PHB matrices.  230 
 231 
3.4. Antiviral activity of active multilayer films following the ISO 22196:2011at 37 °C 232 
and 100% RH (relative humidity) 233 
Initially, newly prepared active multilayer films were inoculated with norovirus 234 
surrogates and HAV adapting the ISO 22196:2011 and incubated at 37 °C and 100% 235 
RH. After ON exposure, no infectious FCV were recovered when in contact with the 236 
active multilayer films while MNV and HAV titers decreased by 2.75 and 0.29 log10 237 
TCID50/ml, respectively (Table 3). 238 
The effectiveness of active multilayer films were further evaluated after pre-239 
conditioning films at 100% RH and 25 °C during 1 month. Thereafter, virus suspensions 240 
were exposed to active multilayer films at 37 °C and 100% RH following the ISO 241 
22196:2011. Table 3 shows that efficacy of stored films slightly decreased, since MNV, 242 
FCV and HAV titers decreased by 1.27, 2.66 and 0.02 log10 TCID50/ml after ON contact 243 
with CNMA films. 244 
 245 
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3.4. Antiviral activity of active multilayer films following the ISO 22196:2011at 25 °C 246 
and 100% RH 247 
To have a further insight into the potential use of CNMA multilayer films, experiments 248 
were performed at 25 °C. When inoculated at high titers, no significant reduction (p < 249 
0.05) of MNV and HAV infectivity was observed whereas 2.2 log10 reductions was 250 
recorded for FCV after ON contact with active multilayer films (Table 4). Moreover, 251 
when low titers of norovirus surrogates were exposed to the CNMA multilayer films, 252 
MNV and FCV titers were reduced by 1.3 and 2.4 log10 after ON contact with CNMA 253 
films at room temperature. For HAV no differences (p > 0.05) in titers reduction were 254 
observed between HAV suspensions inoculated in control films or active multilayer 255 
films (Table 4). 256 
 257 
3. Discussion 258 
As a means of preventing contamination with foodborne pathogens and extending the 259 
shelf-life of foods, antimicrobial packaging is one of the most promising technologies in 260 
the food area. The incorporation of antimicrobial agents in food packaging can be used 261 
to control the microbiota, spoilage microorganisms and even target specific foodborne 262 
pathogens to provide greater safety and to enhance food quality. Although there is an 263 
increasing awareness of the importance of foodborne diseases caused by enteric viruses, 264 
few studies have confronted the task of evaluating materials with antiviral activity 265 
against enteric viruses. In a recent innovative study, an active renewable packaging 266 
material with virucide properties was synthesized by the incorporation of silver ions 267 
into polylactide acid films. These films showed strong antiviral activity on FCV using 268 
the Japanese industrial standard (JIS Z 2801) (Martínez-Abad et al. 2013a). When films 269 
were applied to food samples, antiviral activity was very much dependent on the food 270 
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type and temperature. Likewise, Bright and co-workers (2009) evaluated the antiviral 271 
activity of active packaging, reporting that FCV titers were reduced by 5 log10 when in 272 
contact with plastic coupons impregnated with 10% silver–copper zeolites. 273 
An emerging application for antimicrobial packaging is the incorporation of active 274 
natural compounds. Natural additives have been proposed as potential alternatives to 275 
chemical additives since most of them are categorized as GRAS and due to increasing 276 
consumer demands for safe and “healthy” products.  277 
Assessment of the effect of natural compounds on enteric viruses has mainly been 278 
evaluated on norovirus surrogates (reviewed by D’Souza, 2014; Li et al. 2013; Ryu et 279 
al. 2015) and information about their efficacy on HAV is somewhat limited (reviewed 280 
by Aznar & Sánchez, 2015). Moreover, studies on the use of natural compounds in food 281 
applications are very scarce. So far only carvacrol and grape seed extract (GSE) were 282 
reported as effective natural sanitizers against enteric viruses (Sánchez et al. 2015; Su & 283 
Souza, 2013).  284 
As CNMA films have shown great potential to control foodborne bacteria (De Souza et 285 
al. 2014; Martínez-Abad et al. 2013b; Peng & Li, 2014; Qin et al. 2015; Raybaudi-286 
Massilia et al. 2008), this paper reports the effect of CNMA on virus suspensions at two 287 
different temperatures and contact times. Results showed that incubation with 288 
increasing concentration of CNMA at 37°C for 2 hours increased the antiviral activity 289 
against norovirus surrogates. Furthermore, for the same conditions, CNMA treatment 290 
resulted in slight reductions on HAV infectivity with a maximum reduction of 1 log10 291 
TCID50/ml at the maximum concentration tested. Interestingly, when incubation time 292 
was extended, greater inactivation rates were reported, which may facilitate the final 293 
application in antimicrobial packaging or contact surfaces. 294 
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Active multilayer packaging structures based on PHB and zein interlayers have been 295 
also developed and evaluated in terms of their virucidal activity. Multilayer structures 296 
based on PHB (outer layers) and electrospun zein interlayers have been previously 297 
demonstrated to be the most efficient form to constitute barrier materials (Fabra et al. 298 
2013; 2014) of interest in food packaging. In this work, CNMA was encapsulated 299 
within the electrospun zein interlayer to confer them the active character. This proof-of-300 
concept study should provide an innovative route to develop biodegradable and 301 
renewable active multilayer packaging systems with virucidal activity. The antiviral 302 
activity of CNMA multilayer films was evaluated adapting the ISO intended for the 303 
evaluation of antibacterial activity of plastics and other non-porous surfaces. Overall 304 
CNMA multilayer films showed great potential to inactivate norovirus surrogates while 305 
no virucidal effect was reported for HAV (Table 3). Changes in temperature resulted in 306 
significant differences among the effectiveness of CNMA multilayer systems, 307 
indicating that temperature is a major factor influencing the release or effectiveness of 308 
the active compound. In line with these results, Martínez-Abad and co-workers (2013b) 309 
reported that higher temperatures resulted in an increased antibacterial effect. This 310 
phenomenon could be associated to the diffusion and evaporation rates of the CNMA 311 
being higher with increasing temperature.  312 
Moreover, the CNMA multilayer films are promising for applications to reduce 313 
environmental contamination of food contact surfaces since they proved effective 314 
against norovirus surrogates after one month of production (Table 3).  315 
Overall, this study showed that CNMA treatment, in suspensions and incorporated into 316 
biodegradable multilayer systems, caused greater reduction on norovirus surrogates than 317 
HAV. This behavior has also been observed for other natural compounds, such as 318 
carvacrol, thymol, oregano and zataria essential oils (reviewed by Aznar & Sánchez, 319 
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2015). In contrast, GSE was more effective against HAV than MNV (Su and D'Souza, 320 
2011). As GSE has the potential to be incorporated into edible films (Amankwaah, 321 
2013) future research should consider the combination of both compounds in order to 322 
improve the antiviral efficacy of biodegradable multilayer systems. 323 
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Table 1. Effect of cinnamaldehyde (CNMA) against murine norovirus (MNV), feline 415 
calicivirus (FCV) and hepatitis A virus (HAV) after 2 h of incubation at 4 or 37 °C. 416 
 417 
 418 
Within each column for each virus, different letters denote significant differences between treatments (P < 419 
0.05). 420 
 421 
Virus Treatment Temperature 
4 °C 37 °C 
 CNMA 
concentration 
(%) 
Recovered titer Reduction Recovered titer Reduction
log10 TCID50/ml log10 TCID50/ml 
MNV 0 7.07 ± 0.12A  6.57 ± 0.12A  
0.1 6.45 ± 0.21B 0.62 6.07 ± 0.12A 0.50 
0.5 6.70 ± 0.17B 0.37 5.03 ± 0.07B 1.54 
1 6.57 ± 0.35B 0.50 4.32 ± 0.17B 2.25 
FCV 0 7.16 ± 0.36A  7.53 ± 0.19A  
0.1 7.15 ± 0.08A 0.01 4.24 ± 0.07C 3.29 
0.5 7.16 ± 0.19A 0.00 4.32 ± 0.17C 3.21 
1 7.07 ± 0.00A 0.09 3.37 ± 0.19B 4.16 
HAV 0 6.41 ± 0.19A  6.45 ± 0.15A  
0.1 6.41 ± 0.50A 0.00 6.43 ± 0.25A 0.02 
0.5 6.24 ± 0.14A 0.17 6.24 ± 0.50A 0.21 
1 6.20 ± 0.35A 0.21 5.41 ± 0.07B 1.04 
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Table 2. Effect of cinnamaldehyde (CNMA) against murine norovirus (MNV), feline 
calicivirus (FCV) and hepatitis A virus (HAV) after overnight incubation at 4 or 37 °C. 
 
Within each column for each virus, different letters denote significant differences between treatments (P < 
0.05). 
 
 
 
 
 
 
 
 
Virus Treatment Temperature 4 °C 37 °C 
 
CNMA 
concentration
(%) 
Recovered titer Reduction Recovered titer Reduction
log10 TCID50/ml log10 TCID50/ml 
MNV 
0 6.41 ± 0.36A  4.91 ± 0.19A  
0.1 6.40 ± 0.29A 0.01 3.24 ± 0.07B 1.67 
0.5 6.34 ± 0.19A 0.07 < 1.82B > 3.09 
1 6.39 ± 0.09A 0.02 <1.15B > 3.76 
FCV 
0 6.91 ± 0.19A  No viruses recovered  
0.1 6.78 ± 0.19A 0.13   
0.5 < 4.44B >3.47   
1 < 1.15B >5.76   
HAV 
0 6.16 ± 0.19A  6.03 ± 0.94A  
0.1 6.11 ± 0.07A 0.04 6.00 ± 0.19A 0.03 
0.5 6.15 ± 0.31A 0.01 3.32 ± 0.12C 2.71 
1 6.01 ± 0.08A 0.15 2.66 ± 0.07B 3.37 
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Table 3. Reduction of virus infectivity in contact with cinnamaldehyde (CNMA) multilayer films after production and after one month storage.  
 
 MNV 
(log10 TCID50/ml) 
FCV 
(log10 TCID50/ml) 
HAV 
(log10 TCID50/ml) 
Type of 
multilayer 
films 
Storage 
time (days) 
Recovered 
titer 
Reduction Recovered  
titer 
Reduction Recovered  
titer 
Reduction 
Control 1 4.78 ± 0.31A  3.63 ± 0.19A  5.53 ± 0.38A  
CNMA 
multilayer films 
2.03 ± 0.18B 2.75 <1.15B >2.48 5.24 ± 0.23A 0.29 
        
Control 30 5.03 ± 0.40A  5.91 ± 0.07A  5.45 ± 0.54A  
CNMA 
multilayer films 
3.76 ± 0.08B 1.27 3.25 ± 0.00B 2.66 5.47 ± 0.25A 0.02 
Antiviral effect of CNMA films on virus infectivity after overnight contact adapting the ISO 22196:2011 (37 °C and 100% RH). 
Mean values with different letters in the same column and same solution denote significant differences between treatments (P < 0.05). 
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Table 4. Effect of cinnamaldehyde (CNMA) multilayer films on norovirus surrogates (MNV and FCV) and HAV infectivity after overnight 
contact at 25 °C and 100 % RH. 
 
 
 
 
 
 
 
Antiviral effect of CNMA films on virus infectivity after ON adapting the ISO 22196:2011 (25 °C and 100% RH). 
Mean values with different letters in the same column and same solution denote significant differences between treatments (P < 0.05). 
 
 
 
 
Virus Treatment 
High virus titer 
(log10 TCID50/ml) 
Low virus titer 
(log10 TCID50/ml) 
Recovered titer Reduction Recovered  
titer 
Reduction 
MNV 
Control  5.82 ± 0.45A  4.91 ± 0.26A  
CNMA multilayer 
films 
5.20 ± 0.17A 0.62 3.57 ± 0.00B 1.34 
FCV 
Control 7.19 ± 0.35A  5.66 ± 0.22A  
CNMA multilayer  
films 
4.95 ± 0.79B 2.24 3.26 ± 0.26B 2.40 
HAV 
Control  5.57 ± 0.26A  4.78 ± 0.38A  
CNMA  
multilayer films 
5.54 ± 0.00A 0.03 4.28 ± 0.52A 0.50 
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